UNIVERSITY OF ROCHESTER

Scientists discovered a protein, TIMP3, crucial to AMD onset, using human stem cells to identify a multi-step process leading to drusen accumulation. Inhibiting the inflammatory process reduced drusen deposits, offering potential for new AMD treatments.

Ziresovir, an oral antiviral drug, showed efficacy in reducing bronchiolitis symptoms and RSV viral load in children 2 years and younger hospitalized with RSV infection, with no identified safety concerns in a phase III trial in China. The study results suggest further evaluation in an international trial is warranted.